Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-study.
- DOI
- 10.1093/jac/dkaf319
- Published
- 2025 Nov 4
- Container
- The Journal of antimicrobial chemotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/jac/dkaf319,
title = {Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-study.},
author = {Gelé T and Atwine D and Baudin E and Muyindike W and Mworozi K and Kyohairwe R and Kananura K and Logoose S and Nyehangane D and Nanjebe DKT and Furlan V and Taburet AM and Bonnet M and Barrail-Tran A and ANRS12292 Rifavirenz study group},
year = {2025},
journal = {The Journal of antimicrobial chemotherapy},
doi = {10.1093/jac/dkaf319},
url = {https://doi.org/10.1093/jac/dkaf319}
}RIS
TY - JOUR TI - Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-study. AU - Gelé T AU - Atwine D AU - Baudin E AU - Muyindike W AU - Mworozi K AU - Kyohairwe R AU - Kananura K AU - Logoose S AU - Nyehangane D AU - Nanjebe DKT AU - Furlan V AU - Taburet AM AU - Bonnet M AU - Barrail-Tran A AU - ANRS12292 Rifavirenz study group PY - 2025 JO - The Journal of antimicrobial chemotherapy DO - 10.1093/jac/dkaf319 UR - https://doi.org/10.1093/jac/dkaf319 ER -
APA
T, G., D, A., E, B., W, M., K, M., R, K., K, K., S, L., D, N., DKT, N., V, F., AM, T., M, B., A, B., & group, A. R. S. (2025). Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-study.. The Journal of antimicrobial chemotherapy. https://doi.org/10.1093/jac/dkaf319
Source records
- pubmed · retrieved 2026-09-27T15:50:25.577Z